US Patent 10220079 Suture line administration technique using botulinum toxins
Patent 10220079 was granted and assigned to Allergan, Inc. on March, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 27, 2017
0
Date of Patent
March 5, 2019
0
Patent Applicant
Patent Application Number
15822573
0
Patent Inventor Names
Andrew M. Blumenfeld
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10220079 Suture line administration technique using botulinum toxins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
